Showing results (851-860 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|January 23, 2026
Multi-omics insights into gut microbial dysbiosis and metabolic alterations in immune checkpoint inhibitor-induced thrombocytopeniaBei Xu, Peng Liu, Na Yan, et al.Immunotherapy|February 3, 2026
Combination of anti-PD-1 treatment with chemotherapy in a patient with metaplastic breast cancer during lactationJiaqing Song, Qinghong Yu, Hongting Wu, et al.Immunotherapy|February 12, 2026
Symptoms, symptom burden, and influencing factors in patients treated with NivolumabFerda Akyuz Ozdemir, Dilek Yildirim, Melike Celik, et al.Immunotherapy|January 29, 2026
Cemiplimab in the treatment of cutaneous squamous cell carcinomaLuke S McLean, Annette M Lim, Danny RischinImmunotherapy|November 21, 2025
Ataxia Telangiectasia Mutated (ATM) gene alterations as biomarkers of response to immune checkpoint inhibitorsMaun R Baral, Hassan Abushukair, Maen Abdelrahim, et al.Immunotherapy|December 20, 2024
Anakinra in relapsing polychondritis: a case report and review of the literatureSyed B Ali, Tiffany Hughes, Anthony SmithImmunotherapy|February 5, 2025
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapyThessa Laeremans, Amber Janssens, Joeri L AertsImmunotherapy|February 2, 2025
Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trialsCecilia Nasso, Silvia Puglisi, Sara Elena Rebuzzi, et al.Immunotherapy|December 19, 2023
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case reportLing-Zhijie Kong, Ying Zheng, Kaichun LiImmunotherapy|December 21, 2023
Peripheral B-cell levels predict efficacy and overall survival in advanced melanoma patients under PD-1 immunotherapyXiaoli Liu, Shuochuan Liu, Zhiqiang Jiang, et al.Pageof 188